BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, January 5, 2026
See today's BioWorld MedTech
Home
» Lack of funding threatens Titan's robotic surgery ambitions, now in dash for cash
To read the full story,
subscribe
or
sign in
.
Lack of funding threatens Titan's robotic surgery ambitions, now in dash for cash
Aug. 17, 2016
By
Varun Saxena
Toronto-based Titan Medical Inc. is facing a shortage of R&D funding for its single-port Sport Surgical System robotic surgery device. The company is now scrambling for cash instead of FDA clearance.
BioWorld MedTech
